RFA-DA-25-024-Full-Announcement.html

This document is a Request for Application (RFA) for the "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)" federal grant opportunity.

The purpose of this RFA is to support high-priority research at the intersection of HIV and substance use. It invites innovative research projects with the potential to open new areas of HIV/AIDS research or lead to new prevention, treatment, and cure approaches for people who use drugs (PWUD). Applications must have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This RFA is open to individual researchers and research teams, covering a range of research from basic science to clinical and implementation. All studies must focus on NIH HIV/AIDS Research Priorities.

The funding instrument is a grant, and eligible applicant types include state governments, higher education institutions, non-profit organizations, small businesses, and others. This opportunity is assigned to the Drug Use and Addiction Research Programs (CFDA 93.279) under the Department of Health and Human Services' National Institutes of Health.